Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

TBPHTBPH
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in THERAVANCE BIOPHARMA INC

JPMORGAN CHASE & CO holds 221,846 shares of TBPH (THERAVANCE BIOPHARMA INC), worth $3.8M as of 2026-Q2. The position was increased (+74.3% shares). TBPH represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$3.8M

Current Shares

221,846

Total Value Change

+$1.7M

Total Shares Change

+2,278

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
221,846
+74.3%
$3.8M0.0%$17.00
40
2026-Q1
Decreased
127,267
-69.4%
$1.9M0.0%$13.96
0
2025-Q4
Decreased
416,408
-2.3%
$7.8M0.0%$18.91
0
2025-Q3
Increased
426,208
+256.6%
$6.2M0.0%$14.43
44
2025-Q2
Decreased
119,513
-23.8%
$1.3M0.0%$11.22
0
2025-Q1
Decreased
156,817
-28.6%
$1.4M0.0%$9.23
0
2024-Q4
New
219,568
-
$2.1M0.0%$9.47
36

Other major holders of TBPH: BAUPOST GROUP LLC/MA

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used